Implant-prosthetic treatment in HIV-infected patients receiving highly active antiretroviral therapy: Report of cases

International Journal of Oral and Maxillofacial Implants

Volumn 21, Issue 6, 2006, Pages 951-956

  Strietzel, Frank P ^a   Rothe, Sven ^a   Reichart, Peter A ^a   Schmidt Westhausen, Andrea Maria ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Dental implants; Highly active antiretroviral therapy; HIV positive patients; Immunocompromised patients; Implant supported prosthetic rehabilitation

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; DENTAL CARE; DENTAL SURGERY; DENTURE; EDENTULOUSNESS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MANDIBLE; MIDDLE AGED; MOLAR TOOTH; RETREATMENT; TOOTH CROWN; TOOTH IMPLANTATION; TOOTH PROSTHESIS; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CROWNS; DENTAL CARE FOR CHRONICALLY ILL; DENTAL IMPLANTS; DENTAL IMPLANTS, SINGLE-TOOTH; DENTAL PROSTHESIS, IMPLANT-SUPPORTED; DENTAL RESTORATION FAILURE; DENTURE, COMPLETE, LOWER; DENTURE, OVERLAY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; JAW, EDENTULOUS; MALE; MANDIBLE; MIDDLE AGED; MOLAR; RETREATMENT; VIRAL LOAD;

EID: 33846301115     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Patton LL, Shugars DA, Bonito AJ. A systematic review of complication risks for HIV-positive patients undergoing invasive dental procedures. J Am Dent Assoc 2002;133:195-203.
2. Rajnay ZW, Hochstetter RL. Immediate placement of an endosseous root-form implant in an HIV-positive patient: Report of a case. J Periodontol 1998;69:1167-1171.
3. Baron M, Gritsch F, Hansy AM, Haas R. Implants in an HIV-positive patient: A case report. Int J Oral Maxillofac Implants 2004;19:425-430.
4. Autran B, Carcelain G, Li TS, Mathez D, Tubiana R, Katlama C. Positive effects of combined antiretroviral therapy on CD4+ cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
5. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJJ. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:299-304.
6. Schmidt-Westhausen A-M, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000;29:336-341.
7. Greenspan D, Gange SJ, Phelan JA, et al. Incidence of oral lesions in HIV-1-infected women: Reduction with HAART. J Dent Res 2004;83:145-150.
8. Romeo E, Lops D, Margutti E, Ghisolfi M, Chiapasco M, Vogel G. Long-term survival and success of oral implants in the treatment of full and partial arches: A 7-year prospective study with the ITI dental implant system. Int J Oral Maxillofac Implants 2004;19:247-259.
9. Romeo E, Chiapasco M, Ghisolfi M, Vogel G. Long-term clinical effectiveness of oral implants in the treatment of partial edentulism. Seven-year life table analysis of a prospective study with ITI dental implants system used for single-tooth restorations. Clin Oral Implants Res 2002;13:133-143.
10. Ferrigno N, Laureti M, Fanali S, Grippaudo G. A long-term follow-up study of non-submerged ITI implants in the treatment of totally edentulous jaws. Part 1: Ten-year life table analysis of a prospective multicenter study with 1286 implants. Clin Oral Implants Res 2002;13:260-273.
11. Pjetursson B, Karoussis J, Bürgin W, Brägger U, Lang NP. Patients' satisfaction following implant therapy. A 10-year prospective cohort study. Clin Oral Implants Res 2005;16:185-193.
12. Timmerman R, Stoker GT, Wismeijer D, Oosterveld P, Vermeeren JIJF, van Waas MAJ. An eight-year follow-up to a randomized clinical trial of participant satisfaction with three types of mandibular implant-retained overdentures. J Dent Res 2004;83:630-633.
13. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725-1730.
14. Birnbaum W, Hodgson TA, Reichart PA, Sherson W, Nittayannanta SW, Axell TE. Prognostic significance of HIV-associated oral lesions and their relation to therapy. Oral Dis 2002;8(suppl 2):110-114.
15. Heckmann SM, Heckmann JG, Linke JJ, Hohenberger W, Mombelli A. Implant therapy following liver transplantation: Clinical and microbiological results after 10 years. J Periodontol 2004;75:909-913.
16. Gualini F, Berglundh T. Immunohistochemical characteristics of inflammatory lesions at implants. J Clin Periodontol 2003;30:14-18.
17. Zitzmann NU, Berglundh T, Marinello CP, Lindhe J. Experimental peri-implant mucositis in man. J Clin Periodontol 2001;28:517-523.
18. Lamster IB, Holmes LG, Gross KBW, et al. The relationship of β-glucuronidase activity in gingival crevicular fluid to probing attachment loss in patients with adult periodontitis. Findings from a multicenter study. J Clin Periodontol 1995;22:36-44.
19. Schubert U, Kleber BM, Strietzel FP, Dörfling P. CrossLaps and β-glucuronidase in peri-implant and gingival crevicular fluid. Int J Oral Maxillofac Implants 2001;16:252-258.
20. Shirlaw PJ, Chikte U, MacPhail L, Schmidt-Westhausen A-M, Croser D, Reichart PA. Oral and dental care and treatment protocols for the management of HIV-infected patients. Oral Dis 2002;8(suppl 2):136-143.